YAC-1 cells by treatment of mice with SgSr, indicating that anti-YAC-1 NK cells are M cells (10, 11) . However, unlike marrow allograft reactivity, the lysis of YAC-1 cells in the NK assay did not seem to reflect recognition of Hh antigens (10) . Recently, a weak NK reactivity against EL-4 (H-2 b) lymphoma cells has been described (12) Y.), with 10% fetal calf serum, penicillin and streptomycin, L-glutamine, sodium pyruvate, and nonessential amino acids (complete RPMI-1640 medium). Tissue-culture-maintained EL-4 cells become sensitive to NK activity within 4-6 wk. Before this time, the cells have a very high spontaneous release. Cells at this period in their passage history are frozen and stored in liquid nitrogen. This is necessitated because after -~24 wk in vitro, the genetic specificities reported in Table I tend 
Preparation of Lymphoid Cell
Suspensions. This has been described previously (13) . NK-Cell Assay. 2 × 104 tumor cells in 0.1 ml of RPMI-1640 medium were labeled with SICr (New England Nuclear, Boston, Mass.) and placed in wells of Microtest II plates (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) with varying numbers of freshly harvested lymphoid cells in 0.1 ml of complete RPMI-1640 medium. Generally, each spleencell suspension was plated at four different effector to target-cell (E:T) ratios ranging from 100: 1 to 12.5:1. Cells at each ratio were plated in triplicate. In the case of EL-4 cells, the effectors and targets were incubated for 18 h before the supernatant fluids were collected by Titertek supernate collection system (Flow Laboratories, Inc. Rockville, Md.). When YAC-I or RLdl 2 Luevano, E., V. Kumar, and M. Bennett. Hybrid resistance to EL-4 lymphoma cells II. Role of marrow-dependent (M) cells and marrow-independent cells in vivo. Manuscripl submitted for publication.
were used as targets, the incubation period was four h. The EL-4 cells are not lysed in the NK assay at 4 h. The ~XCr radioactivity in the supernatant fluids was counted in a well-type ~,-scintillation counter. The mean percentage of specific cytotoxicity was calculated as follows:
mean percentage of specific cytotoxlclty = ( Cr cpm, experimental -Cr cpm, spontaneous [medium])/(StCr cpm, maximum [H20] -SlCr cpm, spontaneous) × 100. The variation between the replicates was <10%. Cold competition experiments were performed by fixing the E:T ratio at 50:1 (which is in the linear part of the curve) and the addition of varying numbers of cold (i.e., unlabeled) targets, generally at ratios of 10:1,20:1, and 40:1 ; cold:hot (i.e., labeled). SlCr-release determinations with only labeled and cold targets were performed but they were never significantly different from spontaneous release values. The percentage of specific lysis of EL-4 cells by B6DzF1 spleen cells varied from 9 to 28% in different experiments (E:T ratios of 50:1). Such variation in NK activity has been observed by others (1, 2) . The specificity of the reaction at all levels of cytotoxicity was monitored by including B6D2FI thymus cells and B6 spleen cells as effector cells in most assays. The cytotoxicity produced by these populations was always significantly lower (P <0.01) than that produced by B6DzF1 spleen cells• Mouse Pretreatments. 6-to 8-wk-old mice were injected with two doses of 100 ~Ci 89Sr (Oak Ridge National Laboratory, Oak Ridge, Tenn.) i.p. and utilized 3-6 wk after the last injection. The mortality among B6D2F1 mice by this procedure is ~10%. Silica particles (5-/1m average size, gift from Dr. K. Robock, Steinkohlenberg Vauverein, Essen-Kray, West Germany) were suspended in medium, sonicated, and then injected i.v. (2.5 mg/mouse) or used in vitro (100 /tg/well). Corynebacterium parvum was a gift of Dr. J. Hunter, Wellcome Laboratories, Raleigh, N. C. Mice were injected 2.1 mg (in 0.3 ml) i.p. Polyinosinic:polycytidylic acid (pI:pC) (Sigma Chemical Co., St. Louis, Mo.) was injected i.p. (0.12 mg/mouse). Cyclophosphamide (CY) was a gift from Mead Johnson & Co., Evansville, Ind.; mice were injected with 300 mg/kg body weight. Hydrocortisone.acetate (Merck, Sharp & Dohme, West Point, Pa.) was injected i.p. (2.5 mg). Mice and cells were irradiated in a small-animal irradiator (Gammacell 40, Atomic Energy of Canada Ltd., Commercial Products, Ottawa, Ontario, Canada, dual I:~7Cs sources, 136 rad/ min).
Cell Pretreatments. Filtration over Sephadex G-10 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) columns was done by the method of Ly and Mishell (14) . Yields of nonadherent cells varied between 40 and 50%. Treatment with anti-Ig and complement has been described (15) . Treatment with anti-Thy-l.2 and complement was performed by the protocol described earlier. The anti-Thy-1.2 used is a monoclonal antibody derived from a hybridoma (New England Nuclear, Boston, Mass.). This ~reparation, which is presumably free of any contaminating anti-Ly activity, has a titer of 1:10 . In preliminary characterization studies, a 1:3,000 dilution of this preparation lysed 100% B6D2FI thymus cells, suppressed splenic concanavalin A (Con A) response by 90%, did not affect B-cell mitogenesis, and suppressed cytolytic T-cell activity completely. B6D2F1 spleen cells were treated with a very high concentration of this preparation (1:500) before being tested in the NK assay.
Formation of Tumor-Cell and Other Monolayers, and Cell Adsorptions. Monolayers of tumor or other cells were prepared by some modification of previously described methods (16, 17) . Essentially, poly-L-lysine (PLL) (50 #g/ml) was coated on plastic 60-mm Petri dishes (Falcon Labware, Div. of Becton, Dickinson & Co.) at room temperature for 1 h. After washing off the PLL with phosphate-buffered saline (PBS, pH 7.4), 2 ml of tumor-cell suspension (40 × 106/ ml) were plated on the dish and allowed to stay at room temperature for 45 min. Nonattached tumor cells were then poured off and the Petri dishes were rinsed with PBS. 40 × 106 spleen cells in complete RPMI-1640 medium (20 × 106/ml) were poured on the tumor-coated dishes, and incubated at 37°C for 45 min. At the end, the nonadherent spleen cells were gently poured off and the dishes were washed once with 2 ml complete RPMI-1640 medium. The yield of nonadherent cells by this procedure was 30-40%• The contamination of nonadherent spleen cells by the tumor cells used to make monolayers was carefully monitored (on the basis of cell size) and was never >7%. Monolayers with sheep erythrocytes (SE) and 7S antibody-coated sheep erythrocytes (SEA) were prepared exactly as described (18) .
Generation of Anti-Parent Cytotoxic T Lymphocytes. A modification of the method described by Shearer and Cudkowicz was used (6) . 25 Table I ). The opposite was also true, i.e., CBA, B6, DBA/2, and A-strain mice are poor responders to B8 or B 10 marrow grafts and their spleen cells did not lyse EL-4 cells effectively. CBA and B6 spleen cells lyse YAC-1 but not EL-4 cells well, whereas A-strain spleen ceils lyse both targets poorly. These data extend the earlier findings with the EL-4 NK assay in that /r-like gene functions against Hh-1 b antigens (4) are detected in addition to hybrid resistance (12) .
Tissue Distributions of NK Activity against EL-4 Lymphoma. NK activity of lymphoid tissues from B6 and B6D2F1 mice against EL-4 and YAC-1 targets was compared (Table II ). All B6D2F1 tissues tested showed NK activity against EL-4 and, in each instance, F1 cells killed the target better than B6 parental cells. Lysis of EL-4 cells was maximal by spleen, lymph node cells, and peritoneal cells. Bone marrow was relatively poor. Peritoneal cells and bone-marrow cells had very little NK activity against YAC-1 as previously described (9, 10) . Table I . § See Table I .
TABLE [

Strain Distributwn of NK Activity against EL-4 and YAC-I Tumor Cells
Characterization of the Anti-EL-4 NK Cells.
NK activity against EL-4 cells was present in spleen-cell suspensions of BALB/c nu/nu mice and was not sensitive to treatment with rabbit anti-mouse Ig and complement (Table III) . Filtration of spleen cells over Sephadex G-10 columns and adhesion to plastic did not remove the NK cells. These features suggest that the cells are similar to those described for other NK cells (9, 10) . However, unlike the NK cells against YAC-1 (10) and RLdl targets, the anti-EL-4 NK cells were not affected by injection of mice with silica or incubation with silica particles in vitro. Furthermore, anti-EL-4 NK cells could not be adsorbed by monolayers of SEA (18) . Thus, anti-EL-4 NK cells do not bear Fc receptors. The efficacy of the removal of Fc + cells in the same experiment was ascertained by testing antibody-dependent cellular cytotoxicity (ADCC) against antibody-coated chicken erythrocytes. ADCC was reduced by 80%. In our hands, adsorption over SEA monolayers consistently enriches for NK activity against EL-4. Pretreatment of cells with a high-titered monoclonal anti-Thy-l.2 preparation and complement did not affect the NK activity against EL-4 cells. However, the very same anti-Thy-1.2-treated cells showed a 25-37% reduction in NK activity against YAC-1 cells.
NK Activity against EL-4, YA C-1, and RLc~ I Targets in Spleens of ~Sr-treated Mice. Lysis
of EL-4 cells was normal in 7 out of 10 experiments performed at different times, using pooled spleen cells from two 89Sr-treated B6D2Fa mice in each experiment (Table  IV) . In the other three experiments, lysis of EL-4 cells by spleen cells from 89Sr-treated mice was reduced by ~70%. On the other hand, NK activity against YAC-1 and RLdl was consistently reduced by 70-80% in 89Sr-treated mice. NK activity against YAC-1 is detected routinely in a 4-h assay and 18 h is required for lysis of EL-4. It was therefore important to ascertain if normal lysis of EL-4 target by spleen cells of 89Sr-treated mice was not an artifact produced by a longer incubation time. To this end, we performed the anti-YAC-I NK assay for 18 h, and still failed to observe lysis by spleen cells from a9Sr-treated mice. The converse, i.e., 4-h anti-EL-4 assay, cannot be performed because spleen cells from normal mice fail to lyse EL-4 cells as rapidly. (Table V) . Moreover, the loss of NK activity against YAC-1 cells associated with ages >12 wk (9, 10) did not occur for NK cells capable of lysing EL-4 cells.
Effect of Filtration of Spleen Cells over Sephadex G-IO Columns.
In 89Sr-treated mice, the NK activity against EL-4 cells was reduced in only 30% of the experiments (Table  IV) . In two of those instances, spleen cells of control and SgSr-treated mice were filtered over Sephadex G-10 columns. Sephadex G-10 filtration restored NK-cell activity against EL-4 cells but not against YAC-1 cells ( B6D2F1 mice were irradiated and repopulated with inocula of 1 × 106 marrow cells or 6 × 106 spleen cells from syngeneic donor mice so as to provide equivalent numbers of hemopoietic colony-forming cells (20) . Recipient spleens tested at different intervals after cell transfer were inactive for NKcell function against EL-4 and YAC-1 targets on day 7 (Table VII) . NK cells against EL-4 targets were generated to near-normal levels by both spleen and marrow precursors by day 14. Marrow cells generated NK cells for YAC-1 targets more rapidly than did spleen cells. Such data are consistent with the concepts of separate NK-cell lines or two separate stages in differentiation of a common cell line (the anti-EL-4 cells preceding the anti-YAC-1 cell).
Effects of CY, Hydrocortisone Acetate, C. parvum, and pI:pC on NK-Cell Function. These agents had similar effects on both types of NK cells (Table VIII) (Table IX) . The same was true for "~lCr-labeled EL-4 cells. These data indicate that both types of NK cells recognize both types of lymphoma cells, despite differences in the nature of the two cells and the time required for lysis in the two assays.
Adsorption of Anti-EL-4 and Anti-YAC-1NK Activity by EL-4 and YAC-I Monolayers.
It was important to verify the conclusions arrived at by cold competition by an independent approach. We prepared monolayers of YAC-1 and EL-4 cells on PLLcoated Petri dishes. Spleen cells were then incubated for 45 rain at 37°C on each of the two monolayers. Following this, the nonadherent spleen cells from each monolayer were gently eluted and tested for NK activity on EL-4 and YAC-1 targets. It was reasoned that if YAC-1 and EL-4 cells shared some common antigen and if the anti-YAC-1 and anti-EL-4 cells shared receptor structures for the common antigens, adsorption of cells over either of the two monolayers would simultaneously deplete NK activity against both the targets. Nonadherent cells recovered from YAC-1 or EL-4 monolayers were almost completely depleted of NK activity against both the targets (Table X) B6D2Ft thymus cells, SE, or DBA/2 L1210 tumor cells did not affect NK activity against either target, indicating a specificity for NK cells. A possible source of error in such experiments can arise from detachment of tumor cells forming the monolayers during the elution of nonadherent cells. The tumor cells mixed with the eluted cells could then act as cold competitors in the next step of the assay. We carefully monitored for such contamination (Methods) and found that detached tumor cells constituted 25% of the nonadherent population. Using an E:T ratio of 50:1, this degree of contamination would result in a cold:hot target ratio of ~-2:1, which is far below that required to produce significant cold competition (Table IX) .
Effect of Various Imrnunoregulatory Agents on NK Activity of B6D2F~ Spleen Cells against YAC-I and EL-4 Cells
TABLE X
Adsorption of NK Activity against EL-4 and YAC-l Cells by EL-4 and YA C-1 Monolayers
Lysis of EL-4 and YAC-I cells by B6D2FI-Anti-B6 Effector Cells Induced In Vitro. B~D2F1-
anti-Be cytotoxic T cells were generated in a cell-mediated lympholysis (CML) system (Table XI) . The L1210 tumor cells, which are very poor targets for NK cells, were not lysed by these Fl-anti-parent cytotoxic T cells. Genetic resistance to hemopoietic allografts and NK-cell activity against hemopoietic tumors are two unusual phenomena that appear to have several similarities (10) . However, the exact relationship between the effector cells responsible for the two activities is not entirely clear. Although several studies of NK cells have appeared recently, the interrelationship between NK cells active against various tumor target cells has not been elucidated. The studies reported here addressed this problem, NK activity against tissue culture-adapted EL-4 cells has several features that distinguish it from NK activity against YAC-1 and RLc~I cells, two target cells widely used to investigate NK cells. NK cells for YAC-1 (10, 1 1) or RL~I cells (Table IV) and viral-induced NK cells (21) are depleted in mice treated with Sgsr, indicating that such NK cells require an intact marrow microenvironment for some critical stage in differentiation. Thus these cells are similar to M cells which have been previously suggested to be effector cells responsible for marrow ailograft reactivity (5), genetic resistance to the leukemic and immunosuppressive effects of Friend virus (22) , resistance to infection with Listeria monocytogenes (23) , and genetic resistance to encephalomyelitis induced by herpes simplex virus-1 (24) . However, because we have also observed an increase in thymus-dependent and thymus-independent suppressor cells in spleens of mice treated with 89Sr (15, 25) , the possibility that poor NK-cell function in 89Sr-treated mice is due to suppressor cells rather than to depletion of effector M cells must be considered. We feel this is unlikely because we have been unable to detect any suppressor cells for anti-YAC-1 NK activity by a variety of techniques previously utilized to detect suppressor cells in S9Sr-treated mice (15, 25) . 3 It should be pointed out that the effects of 89Sr administration on the lymphoid system are fairly specific. After 89Sr treatment, several thymus-dependent-cell, bursa equivalent-dependent-cell, and macrophage functions and/or numbers assessed by a variety of assays remain normal (26) . Study of 89Sr-treated mice allows the distinction to be made between those immune cells that are normally marrow-derived but not M (e.g., T cells, B cells, macrophages) and those which are not only marrow-derived but are also M cells (e.g., anti-YAC-1 NK cells). In 89Sr-treated mice the spleen takes over stem-cell functions and the marrow-independent cells can differentiate normally.
In contrast to NK cell-activity against YAC-I and similar targets discussed above, the NK-cell activity against EL-4 cells was not usually affected by treatment of mice with 89Sr. In the few instances where NK activity against EL-4 cells was low in 89Sr-treated mice, the effect was apparently due to presence of suppressor cells rather than to a lack of EL-4 NK cells, because the low NK activity against EL-4 could be restored to normal by filtration over Sephadex G-10 columns. 2 (Also, Table VI .) Note that in the same experiment, the low NK activity against YAC-1 could not be reversed by filtration over Sephadex G-10 columns. To our knowledge, this is the first demonstration of two biologically (or developmentally) distinct classes of NK cells in mice: (a) M cells, and (b) marrow-independent (non-M) cells. Further support (but not proof) for such a conclusion comes from the comparative study of ontogeny of NK cells and their generation in irradiated recipients. M-cell activity as measured by marrow allograft reactivity (1) and resistance against Friend virus leukemia (13) does not develop until mice are 3 wk old; similarly, NK-cell activity against YAC-1 cells does not develop until mice are ~18-20 d old (Table V , and [10] ). On the other hand, normal NK-cell activity against EL-4 cells is present as early as 5 d after birth. In adoptive transfer experiments, it has been seen that M-cell functions (marrow allograft reactivity, early resistance against Listeria monocytogenes) are more efficiently generated in irradiated syngeneic recipients by bone-marrow cells than by spleen cells (27, 28) . This could be explained by the higher frequency of M-cell precursors in the bone marrow, as compared with the spleen. Correspondingly, the NK activity against YAC-1 cells was much more rapidly generated in irradiated mice repopulated with bone-marrow cells, as compared with recipients of normal spleen cells, even though six times as many spleen cells were transplanted to correct for the relative frequencies of the pluripotent stem cells. In contrast, NK-cell activity against EL-4 cells was generated within 15 d after transfer of spleen or bone-marrow cells. Another distinction between anti-YAC-I and anti-EL-4 cells is the susceptibility to anti-Thy-l.2 and complement. NK activity against EL-4 cells is not affected by pretreatment of the cells with a high-titered monoclonal anti-Thy-l.2 and complement, whereas, in agreement with the observation of others, the NK activity against YAC-1 cells is reduced by ---30% (29) .
It must be pointed out that there are also certain similarities between the anti-YAC-1 and anti-EL-4 NK cells. Both the activities are stimulated 3 d after injection of C. pawum and suppressed 13 d after C. parvum injection or by hydrocortisone acetate and CY. As discussed later in this paper, these findings are consistent with the notion that anti-EL-4 NK cells may be the precursors of anti-YAC-1 NK cells.
The nature of the target structures on most NK-sensitive tumor cells is still not clear. However, in the case of tissue-culture-adapted EL-4 cells, it seems very likely that the critical target antigen is the same as, or similar to, the Hh-1 b antigen. This antigen is expressed on primitive hemopoietic cells of the C57BL/6 (H-2 b) mice and appears to be the relevant antigen in the rejection of B6 bone-marrow cells by irradiated mice. The Hh-I locus has been mapped at, or close to, the D-end of H-2 complex and is not expressed in the heterozygous state, resulting in the rejection of B6 bone-marrow cells by B6DzFI hybrid mice (hybrid resistance) (3). Our suggestion that Hh-I b antigen is the critical target structure in the lysis of EL-4 cells in the NK assay is based on the strong immunogenetic correlation between NK activity against EL-4 cells in vitro and rejection of B6 bone-marrow grafts in vivo. This can be summarized as follows: (a) hybrid resistance is seen against B6 bone-marrow grafts in vivo and in the NK-cell activity against EL-4 in vitro. This phenomenon cannot be due to dominant/r-like genes inherited from the opposite parent, because the DBA/2 parent itself is both a poor responder to B6 bone-marrow allografts in vivo and shows poor NK activity against EL-4 cells in vitro (Table I) . Furthermore, when spleen cells from a number of F1 mice derived from intra-H-2 recombinant parents were tested (12) , it was found that heterozygosity at the D-end of H-2 was critical for lysis of EL-4 cells in the NK assay. Heterozygosity at other parts of the H-2 complex was neither necessary nor sufficient for hybrid resistance in the NK assay. The fine genetics of hybrid resistance against parent Hh-1 b antigens in vivo is similar to that seen in the NK assay, i.e., only those F1 mice that are heterozygous at H-2D b reject B6 bonemarrow cells; (b) among inbred strains, reactivity against EL-4 in vitro and B~ bonemarrow grafts in vivo is regulated by non-H-2 genes on the C57BL background. For example, both DBA/2 and B10.D2 are Hh-l incompatible with Bb, but B10.D2 mice are good rejectors of B6 bone-marrow grafts, whereas DBA/2 mice are poor responders (30) . The anti-EL-4 NK reactivity of spleen cells from DBA/2 and B10.D2 mice follows the same pattern. Other such examples can be seen in Table I .
Because the genetic pattern of NK reactivity against the YAC-1 does not correspond to the anti-EL-4 NK reactivity or anti-B6 (Hh-1 b) bone-marrow reactivity in vivo, it appears unlikely that the lysis of YAC-1 cells is mediately solely by recognition of Hh-1 b antigens in vitro. However, cold competition experiments and adsorption experiments (Tables IX and X) One of the objectives of our work has been to develop an in vitro assay that would reflect all aspects of in vivo marrow allograft reactivity. The NK activity against EL-4 fulfills most of the immunogenetic requirements for such an assay, but seems not to reflect the in vivo situation entirely because the anti-EL-4 activity is retained in 89Sr-treated mice. On the other hand, the anti-YAC-1 NK reactivity parallels many facets of marrow graft rejection except for immunogenetic specificity. It is tempting to speculate that both M cells and non-M cells are required for marrow allograft reactivity in vivo and that the complex effector-cell system has been dissected in vitro. Received for publication 12 March 1979. 
